SEARCH:   Advanced

Blood, 1 February 2008, Vol. 111, No. 3, pp. 1404-1412. Prepublished online as a Blood First Edition Paper on November 6, 2007; DOI 10.1182/blood-2007-09-113761. This Article Full Text (PDF) Supplemental Figure All Versions of this Article: blood-2007-09-113761v1 111/3/1404    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Nishikawa, H. Articles by Gnjatic, S. Search for Related Content PubMed PubMed Citation Articles by Nishikawa, H. Articles by Gnjatic, S. Social Bookmarking                   What's this?  Previous Article  |  Next Article  Submitted September 19, 2007 Accepted October 28, 2007 Induction of regulatory T cell-resistant helper CD4+ T cells by bacterial vector Hiroyoshi Nishikawa, Takemasa Tsuji, Elke Jager, Gabriel Briones, Gerd Ritter, Lloyd J Old, Jorge E Galan, Hiroshi Shiku, and Sacha Gnjatic* Ludwig Institute for Cancer Research, Memorial Sloan-Kettering Cancer Center, New York, NY, United States Medizinische Klinik II, Hamatologie-Onkologie, Krankenhaus Nordwest, Frankfurt, Germany Section of Microbial Pathogenesis, Yale University School of Medicine, New Haven, CT, United States Department of Immuno-Gene Therapy, Mie University Graduate School of Medicine, Tsu, Mie, Japan * Corresponding author; email: gnjatics{at}mskcc.org. Salmonella typhimurium engineered to deliver cancer/testis antigen NY-ESO-1 through type III secretion (S. typhimurium-NY-ESO-1) was shown to be an efficient cancer vaccine construct in mice and to stimulate NY-ESO-1-specific CD8+/CD4+ T cells in vitro in cancer patients with NY-ESO-1 spontaneous immunity. We also showed that individuals without spontaneous immunity to NY-ESO-1 had specific CD4+ T cell precursors with high-avidity to NY-ESO-1 under tight control by CD4+CD25+ regulatory T cells (Tregs). We now found that in healthy donors and melanoma patients without NY-ESO-1 spontaneous immunity, S. typhimurium-NY-ESO-1 elicits CD4+ T helper 1 (Th1) cells in vitro recognizing naturally processed antigen from these high-avidity NY-ESO-1-specific naive precursors. In contrast to peptide stimulation, induction of specific Th1 cells with S. typhimurium-NY-ESO-1 did not require in vitro depletion of CD4+CD25+ Tregs and this prevailing effect was partially blocked by disruption of interleukin-6 or glucocorticoid-induced TNF receptor (GITR) signals. Furthermore, S. typhimurium-induced Th1 cells had higher GITR expression than peptide-induced Th1 cells and were resistant to suppression by CD4+CD25+ Tregs in a GITR dependent fashion. We propose that S. typhimurium-NY-ESO-1 induces antigen-specific T cell responses that are resistant to suppression by CD4+CD25+ Tregs. CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this? This article has been cited by other articles: H. Nishikawa, T. Kato, M. Hirayama, Y. Orito, E. Sato, N. Harada, S. Gnjatic, L. J. Old, and H. Shiku Regulatory T Cell-Resistant CD8+ T Cells Induced by Glucocorticoid-Induced Tumor Necrosis Factor Receptor Signaling Cancer Res., July 15, 2008; 68(14): 5948 - 5954. [Abstract] [Full Text] [PDF]

	Copyright © 2007 by American Society of Hematology         Online ISSN: 1528-0020